Our clinic remains open for participant study visits during all alert levels.  ||  Our US Toll Free #: 1844 264 6291

Atopic Dermatitis study

Do you have moderate-to-severe ATOPIC DERMATITIS that is impacting your quality of life?

A new study is investigating the effectiveness and safety of an investigational medication for moderate-to-severe Atopic Dermatitis. This medication may help relieve your symptoms.

Trial requirements:

  • Aged 18 years and above
  • Have a doctor’s diagnosis of chronic Atopic Dermatitis for at least 1 year
  • History of inadequate response to stable regimen of topical corticosteroid or calcineurin  inhibitors (drug that act on the immune system to reduce skin inflammation) within 3 months

Please consider joining this clinical trial to receive this investigational medication for a period of 16 weeks.

Please speak to your doctor if you/your friends/family are interested. By joining this study, you will be helping others by contributing to Atopic Dermatitis research.

A new study is investigating the effectiveness and safety of an investigational medication for moderate-tosevere Atopic Dermatitis.

If this sounds of interest, then simply register your details below and we'll be in touch.

Name

Email address

Phone number (optional)

Message